Metastatic Renal Cell Carcinoma Recruiting Phase 2 Trials for Ribose (DB15073)

Back to Metastatic Renal Cell Carcinoma

Also known as: Metastatic renal cell carcinoma (morphologic abnormality) / Metastatic renal cell carcinoma (disorder)

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03682289Phase II Trial of AZD6738 Alone and in Combination With OlaparibTreatment